Add BrightSurf on Google Email

Mayo Clinic


Case report: Stem cells a step toward improving motor, sensory function after spinal cord injury

A clinical trial enrolled 10 adults with traumatic spinal cord injuries to receive stem cell injections, with the first patient demonstrating significant improvement in motor and sensory functions. The study's early findings suggest that patient response varies, but the treatment may offer a new option for improving physical function a...

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateNov 27, 2019

Mayo scientists reverse fibrosis in preclinical studies

Researchers at Mayo Clinic have identified a way to slow and reverse fibrosis by targeting a dopamine receptor, which blocks the growth of scar-forming cells. The approach reversed fibrotic processes in lung and liver models, offering a new treatment concept for fibrotic diseases.

SourceMayo Clinic·JournalScience Translational Medicine·DateOct 30, 2019

Mayo Clinic studies patient privacy in MRI research

A Mayo Clinic study reveals that commercial facial recognition software can accurately identify people from brain MRI scans, even with image face removal. The study found an 83% success rate in identifying participants using publicly available facial recognition software.

SourceMayo Clinic·JournalNew England Journal of Medicine·DateOct 23, 2019

Burnout symptoms associated with racial bias in medical residents

A recent study by Mayo Clinic researchers found an association between increased symptoms of burnout and heightened racial bias in medical residents. Physicians experiencing high symptoms of burnout tended to exhibit more racial bias, both explicit and implicit, but recoveries from burnout were linked to reductions in bias.

SourceMayo Clinic·JournalJAMA Network Open·DateJul 26, 2019

Stem cell therapy furthers research for infants with hypoplastic left heart syndrome

A phase I clinical trial demonstrates the potential of regenerative therapy for hypoplastic left heart syndrome through collecting, processing and injecting an infant's own stem cells directly into the heart at the time of surgery. The study showed no deaths or significant safety concerns over six months following surgery.

SourceMayo Clinic·JournalJournal of Thoracic and Cardiovascular Surgery·DateJul 22, 2019